6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
6m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
6m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
6m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
7m ago	When Blood Compatibility Becomes a Pregnancy Risk
7m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

331.15USD-0.43 -0.13%

Closed • Updated at 13:54 GMT+00:00

Market Cap$178.72B

P/E Ratio23.03

Volume54.9K

Beta0.39

RSI44.24

Gross Margin71.51%

Health TechnologyBiotechnology

Amgen Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH

Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

Bi/Multispecific Drugs in Oncology Analytical Tool Featuring Top Developers - Amgen, Hoffmann-La Roche, J&J, Xencor, Biocytogen - Unlocking New Precision, Immune Activation, and Therapeutic Potential

Procrit (Amgen) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR

Community Chat

Ask AI